[乳腺癌的组织学切缘及残留病灶评估]
[Histological margin and residual disease assessment for breast carcinoma].
作者信息
Sigal-Zafrani B, Fourquet A, Vincent-Salomon A, Fréneaux P, Génin P, Rosty C, Sastre-Garau X
机构信息
Département de biologie des tumeurs, de radiothérapie, Institut Curie, 26, rue d'Ulm, 75005 Paris, France.
出版信息
Cancer Radiother. 2003 Nov;7 Suppl 1:120s-123s.
PMID:15124553
Abstract
Margin and histological size of ductal in situ carcinoma or intraductal component of an infiltrative carcinoma are important prognostic factors to predict presence/absence as well as amount of residual tumor burden. Their evaluation requires standardized pathological analysis. These factors should be interpreted in clinical and radiological context.
摘要
导管原位癌或浸润性癌的导管内成分的切缘和组织学大小是预测残余肿瘤负荷的有无及数量的重要预后因素。对它们的评估需要标准化的病理分析。这些因素应结合临床和影像学情况进行解读。
Zotero 插件